Ledger.Open graph →
SEC Form D · filed November 20, 2017

Exonics Therapeutics, Inc

Offering
$42.0M
Sold
$22.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

David J. Goeddel · Cambridge, MADirectorH. J. Magee · Cambridge, MAExecJohn Ripple · Cambridge, MAExec · DirectorJeenjoo J. Kang · Cambridge, MADirectorJohn Ripple · Cambridge, MAExec · DirectorDavid J. Goeddel · Cambridge, MADirectorH. J. Magee · Cambridge, MAExecJeenjoo J. Kang · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗